China · Venture startup

Who invested in Immunochina

2 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$20Mraised across 2 rounds since 2019, from 2 sources

Latest round
VentureJan 2025
Biggest round
$20MRound · Jan 2019
Investors
7
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2019202020212022202320242025
$20MRound?Venture
First round
Round, $20M
Jan 2019
Biggest round
$20M
Round · Jan 2019
Between rounds
5.9 years
from the last two

The rounds

  1. Jan 2025
    VentureAmount undisclosed3 new

    Source recorded

  2. Jan 2019
    Round$20M4 new

    Reported by FinSMEs

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Legend CapitalVC firm1round
Peter ThielAngel1round
Foothill VenturesVC firm1round
Shougang FundInvestment firm1round
Qingzhe Capitalno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Immunochina

Who invested in Immunochina?

Immunochina's investors include Legend Capital, Peter Thiel, Foothill Ventures, Sherpa Healthcare Partners and Shougang Fund, and 2 more on record.

How much has Immunochina raised?

Immunochina has raised $20M across 2 rounds since 2019. One round did not disclose an amount, so the total is a floor.

When did Immunochina last raise?

Immunochina's most recent round was a Venture in Jan 2025.

What was Immunochina's biggest round?

Immunochina's largest round on record is $20M (Undisclosed round), in Jan 2019.

Who backed Immunochina first?

Immunochina's first round on record, in Jan 2019, was backed by Peter Thiel, Shougang Fund and Sherpa Venture Capital and 1 others.

What stage is Immunochina at?

Immunochina's latest named round is a Venture, in Jan 2025.

Where is Immunochina based?

Immunochina is based in China.

Companies like Immunochina

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.